1-116535967-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001779.3(CD58):c.626G>A(p.Ser209Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000642 in 1,603,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001779.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD58 | NM_001779.3 | c.626G>A | p.Ser209Asn | missense_variant, splice_region_variant | 3/6 | ENST00000369489.10 | NP_001770.1 | |
CD58 | NM_001144822.2 | c.626G>A | p.Ser209Asn | missense_variant, splice_region_variant | 3/5 | NP_001138294.1 | ||
CD58 | NR_026665.2 | n.680G>A | splice_region_variant, non_coding_transcript_exon_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD58 | ENST00000369489.10 | c.626G>A | p.Ser209Asn | missense_variant, splice_region_variant | 3/6 | 1 | NM_001779.3 | ENSP00000358501 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151956Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000218 AC: 54AN: 247600Hom.: 0 AF XY: 0.000149 AC XY: 20AN XY: 134248
GnomAD4 exome AF: 0.0000682 AC: 99AN: 1451544Hom.: 0 Cov.: 31 AF XY: 0.0000485 AC XY: 35AN XY: 721222
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151956Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74182
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2022 | The c.626G>A (p.S209N) alteration is located in exon 3 (coding exon 3) of the CD58 gene. This alteration results from a G to A substitution at nucleotide position 626, causing the serine (S) at amino acid position 209 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at